US Patent 7923007 Brain tissue damage therapies
Patent 7923007 was granted and assigned to Academia Sinica on April, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+252 characters)
Article
Patent abstract
A cultured pluripotent animal cell that is CD13+, CD90+, and CD117−. Also disclosed are methods for making the cell and methods of treating a brain tissue damage and increasing the expression level of a neuraltrophic factor in a subject.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Dah-Ching Ding0
Hung Li0
Shin-Zong Lin0
Woei-Cherng Shyu0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07923007 Brain tissue damage therapies US Patent 7923007 Brain tissue damage therapies
Infobox
Patent Number
07923007
Patent Number
7923007
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07923007 Brain tissue damage therapies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07923007
Date of patent
April 12, 2011
Patent application number
11462426
Date Filed
August 4, 2006
Patent primary examiner
Find more entities like US Patent 7923007 Brain tissue damage therapies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.